Surgery during chemotherapy and at relapse of ovarian cancer

被引：44

作者：

Berek, JS ^{[1
]}

Tropé, C

Vergote, I

机构：

[1] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Med, Womens Gynecol Oncol Ctr, Los Angeles, CA 90095 USA

[2] Katholieke Univ Leuven Hosp, Louvain, Belgium

[3] Norwegian Radium Hosp, Oslo, Norway

来源：

ANNALS OF ONCOLOGY | 1999年 / 10卷

关键词：

D O I：

10.1023/A:1008338830718

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

During chemotherapy and after relapse several types of operations are used in ovarian cancer: secondary cytoreductive surgery, interval cytoreductive surgery, second-look surgery, and palliative secondary surgery. The role of these operations has been difficult to define because there is considerable variation in the patterns of behaviour of tumours among those with persistent or recurrent disease. The definitions, indications and impact of these procedures are reviewed.

引用

页码：3 / 7

页数：5

共 60 条

[51] CONCLUSIONS AND RECOMMENDATIONS FROM THE HELENE-HARRIS-MEMORIAL-TRUST 5TH BIENNIAL INTERNATIONAL FORUM ON OVARIAN-CANCER, MAY 4-7, 1995, GLASGOW, UK [J].

SHARP, F ;

BLACKETT, AD ;

LEAKE, RE ;

BEREK, JS .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (06) :449-458

[52] Neoadjuvant chemotherapy for advanced ovarian cancer [J].

Surwit, E ;

Childers, J ;

Atlas, I ;

Nour, M ;

Hatch, K ;

Hallum, A ;

Alberts, D .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 (05) :356-361

[53] THE MANAGEMENT OF OVARIAN-CANCER-CAUSED BOWEL OBSTRUCTION [J].

TUNCA, JC ;

BUCHLER, DA ;

MACK, EA ;

RUZICKA, FF ;

CROWLEY, JJ ;

CARR, WF .

GYNECOLOGIC ONCOLOGY, 1981, 12 (02) :186-192

[54]

VACCARELLO L, 1995, GYNECOL ONCOL, V57, P62

[55] THE EFFECT OF DEBULKING SURGERY AFTER INDUCTION CHEMOTHERAPY ON THE PROGNOSIS IN ADVANCED EPITHELIAL OVARIAN-CANCER [J].

VANDERBURG, MEL ;

VANLENT, M ;

BUYSE, M ;

KOBIERSKA, A ;

COLOMBO, N ;

FAVALLI, G ;

LACAVE, AJ ;

NARDI, M ;

RENARD, J ;

PECORELLI, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (10) :629-634

[56]

VOGL SE, 1983, CANCER, V51, P2024, DOI 10.1002/1097-0142(19830601)51:11<2024::AID-CNCR2820511111>3.0.CO

[57]

2-I

[58]

VOGL SE, 1984, CANCER, V54, P2220, DOI 10.1002/1097-0142(19841115)54:10<2220::AID-CNCR2820541025>3.0.CO

[59]

2-S

[60] PRIMARY OR DELAYED DEBULKING SURGERY AND CHEMOTHERAPY CONSISTING OF CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE IN STAGE-III-IV EPITHELIAL OVARIAN-CARCINOMA [J].

WILS, J ;

BLIJHAM, G ;

NAUS, A ;

BELDER, C ;

BOSCHMA, F ;

BRON, H ;

CEELEN, T ;

EEKHOUT, A ;

VONERP, J ;

GEELEN, P ;

VONGEUNS, H ;

HAEST, J ;

HOOGLAND, H ;

HUISKES, J ;

GANS, HD ;

KORNMAN, J ;

KRUYVER, G ;

LALISANG, F ;

VANDERMEULEN, J ;

MOORMAN, P ;

DEPREE, N ;

STOOT, J ;

TUSHUIZEN, P ;

VREESWIJK, J ;

WALS, J ;

WETZELS, L ;

WILLEBRAND, D .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) :1068-1073

← 1 2 3 4 5 6 →